▲ BUY
5
/ 10
Conviction
$ Value
$21K
Shares
750
Price
$28
Filed
Dec 10
▶ Why this score? (5/10)
- ✓ Open market buy (+3)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
RHOADS ANN D
Title
—
CIK
0001250252
Roles
Director
Transaction Details
Transaction Date
2025-12-10
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
15,021
Filing Info
RHOADS ANN D's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | RPTX | D | — |
| 2026-01-21 | GMED | A | $0 |
| 2025-12-10 | QDEL | ▲ | $21K ★ |
| 2025-11-10 | GMED | ▼ | $170K |
| 2025-11-07 | GMED | ▼ | $648K |
| 2025-09-15 | GMED | ▼ | $585K |
| 2025-08-29 | ITOS | D | — |
| 2025-05-29 | QDEL | A | $0 |
| 2025-05-29 | QDEL | A | $0 |
| 2025-05-29 | QDEL | A | $0 |
Other Insiders at QDEL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Blaser Brian J.
President and CEO
|
$249K | — | 2026-02-13 |
| Strobeck Matthew | $240K | — | 2026-02-13 |
|
Busky Joseph M.
Chief Financial Officer
|
$80K | — | 2026-03-28 |
|
SISITSKY NATHANIEL
Chief Legal Officer
|
— | — | 2026-04-15 |
|
Hodges Michelle A
Chief Legal Officer
|
— | — | 2026-02-08 |
|
Bowman Ronald Lee
Chief Human Resources Officer
|
— | — | 2026-01-30 |
|
Siegrist Jonathan Philip
EVP of R&D & CTO
|
— | — | 2026-01-30 |
|
McLellan Philip D.
Chief Operations Officer
|
— | — | 2026-01-31 |